News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Enzon Pharmaceuticals, Inc. (ENZN) Adopts Stockholder Rights Plan In An Effort To Protect Net Operating Loss Carryforwards


5/1/2014 4:08:24 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PISCATAWAY, N.J.--(BUSINESS WIRE)--Enzon Pharmaceuticals, Inc. (“Enzon” or the “Company”) (Nasdaq:ENZN) announced today that its Board of Directors (the “Board”) has adopted a stockholder rights plan (the “Rights Plan”) in an effort to preserve the value of its net operating loss carryforwards (“NOLs”) under Section 382 of the Internal Revenue Code (the “Code”).

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES